Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Ankrin Therapeutics ApS
APS
Bankrupt
Reklamebeskyttelse
CVR 39788705
Nordre Fasanvej 215, 2000
Frederiksberg
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2018 · 7 years old
4 employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Ankrin Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
-4M
2019
-2M
2020
-2M
2021
-1M
2022
0M
2023
EBITDA
DKK millions
0M
-2M
-3M
-5M
-6M
-5M
2019
-4M
+20%
2020
-5M
-25%
2021
-3M
+40%
2022
-2M
+33%
2023
Income statement
DKK thousands
Item
2019
2020
2021
2022
2023
Gross profit
-3.755
-2.067
-2.427
-1.025
-498
Staff expenses
-1.246
-1.827
-2.725
-2.184
-1.594
EBITDA
-5.002
-3.894
-5.153
-3.209
-2.092
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-5.002
-3.894
-5.153
-3.209
-2.092
Net financials
-357
-448
-390
-294
-594
Profit before tax
-5.359
-4.342
-5.543
-3.503
-2.686
Tax
-966
-857
-1.049
-771
-351
Net profit
-4.393
-3.485
-4.493
-2.733
-2.334
Balance sheet
DKK thousands
Item
2019
2020
2021
2022
2023
Total assets
4.425
10.714
6.579
3.656
1.614
Equity
-4.378
2.781
-1.712
-4.445
-6.779
Long-term debt
7.877
6.965
7.300
7.563
8.108
Short-term debt
926
968
991
538
286
Total debt
8.803
7.933
8.291
8.101
8.394
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-209215200.0%
This company
2019
2023
Soliditetsgrad
-419.9%
This company
38.2%
Market median
-1199% vs market
2019
2023
Egenkapitalforrentning
-233445800.0%
This company
18.4%
Market median
-1268727274% vs market
2019
2023
Nettoresultatgrad (af bruttofortjeneste)
-233445800.0%
This company
2019
2023
Aktivomsætning (af bruttofortjeneste)
-0.31×
This company
2019
2023
Gæld/egenkapital
1.24×
This company
0.62×
Market median
-100% vs market
2019
2023
Annual reports & filings
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via CVR / Virk · Period 2018-08-16 – 2019-12-31
View
PDF
More on Ankrin Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
